Law360 (November 27, 2019, 5:54 PM EST) -- Insys Therapeutics Inc. executives got part of the landmark opioid verdict against them thrown out, showing overreach by Boston federal prosecutors as well as the high bar of evidence needed to prove a conspiracy to distribute legal drugs, experts told Law360.
U.S. District Judge Allison Burroughs on Tuesday knocked down the Controlled Substances Act predicate of the Racketeer Influenced and Corrupt Organizations Act conviction of Insys founder John Kapoor and four other former executives. Judge Burroughs had seemed skeptical of the CSA charge all along, though prosecutors convinced a jury in May that Kapoor and his cohorts conspired to bribe doctors to prescribe...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!